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Background/aim: The optimum duration of antimicrobial prophylaxis in elective gastric cancer surgery is still not yet established. The
aim of this study is to evaluate the efficacy of 24 h or 72 h of antimicrobial prophylaxis for preventing postoperative infection.
Materials and methods: Between July 2016 and January 2018, 990 gastric cancer patients undergoing surgery with D2 lymphadenectomy
in Ren Ji Hospital were classified into 24-h or 72-h antimicrobial prophylaxis groups. The incidence of postoperative infection
complications was compared.
Results: A total of 990 patients (24-h antimicrobial prophylaxis, 708 cases; 72-h antimicrobial prophylaxis, 282 cases) were analyzed.
Surgical site infection (SSI) occurred in 37 patients (5.2%) in the 24-h group and 17 patients (6.0%) in the 72-h group, respectively, and
24-h antimicrobial prophylaxis was not a risk factor for remote infection (11.2% in 24-h versus 10.2% in 72-h group). Age >60 years and
pathological stage III were significantly associated with remote infection.
Conclusion: Compared to 72 h of antimicrobial prophylaxis, 24 h is not a risk factor for either SSI or remote infection. Extended
antimicrobial prophylaxis might decrease remote infections for older patients or those of pathological stage III.
Key words: Gastric cancer, antimicrobial prophylaxis, surgical site infection, remote infection

1. Introduction
Gastric cancer is the fourth most common cancer and
the second most frequent cause of death in the world,
with curative surgery remaining the primary therapeutic
approach for gastric cancer (1). Despite the great progress
made in surgical skills and perioperative management
during the past decades, complication rates after
gastrectomy vary from 10.5% to 40.1% in different medical
centers (2–6). Several studies have reported that the
incidence of complications was regarded as a risk factor
for gastric cancer patients’ prognosis (7,8).
Postoperative application of prophylactic antibiotics
is used to prevent infectious complications, such as
surgical site infection (SSI) or remote infection, for
clean-contaminated surgery. Patients could receive some
benefits from short-term antimicrobial prophylaxis, such
as reducing the development of bacterial resistance and
lowering the expenses (9). The guidelines of the Centers
for Disease Control and Prevention (CDC) recommend
that intravenous antimicrobial prophylaxis be limited to
within 24 h postoperatively (10). However, most of the
previous studies comparing short-term with long-term
antibiotic regimens focused on colorectal surgery (11,12)
or cholecystectomy (13,14). There is not much evidence

about the duration of antimicrobial prophylaxis in relation
to the risk of infectious complications following curative
gastrectomy with D2 lymphadenectomy. This study aims to
investigate the efficacy of 24 h versus 72 h of antimicrobial
prophylaxis in Chinese gastric cancer patients.
2. Materials and methods
Gastric cancer patients between July 2016 and January
2018 undergoing elective surgery at Ren Ji hospital
were included in this study. The surgical procedure
was potentially curable gastrectomy for cancer with D2
lymphadenectomy. Patients were excluded if they were
aged less than 20 or more than 80 years, pregnant, or
allergic to penicillins or cephalosporins; had received
antibiotic treatment in the past 2 weeks; had perioperative
infection or another organ cancer; were of ASA grade
III; had a microscopic or macroscopic residual tumor,
emergent surgery, moderate or severe liver disease
(alkaline phosphatase, alanine aminotransferase, aspartate
aminotransferase, or total bilirubin more than five times
the upper limit of normal), or severe renal impairment
(serum creatinine level above 2.0 mg/dL); or had received
preoperative chemotherapy or chemoradiotherapy and
combined resection. We retrospectively reviewed medical
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histories and postoperative complications. This study was
approved by Ren Ji Hospital’s ethics committee.
This study was designed to investigate the efficacy of
24 h or 72 h of antimicrobial prophylaxis regimens with
cefazolin or quinolones on infectious complications
including SSI and remote infection. Thirty minutes before
the operation both groups received 1 g of cefazolin by slow
intravenous infusion over 15 min. An additional dose
was administered if the operation was prolonged beyond
3 h. For 24-h prophylaxis, postoperative antibiotics
were administered twice in the 24 h after the end of the
surgery. For 72-h prophylaxis, postoperative antibiotics
were given twice daily for 72 h. The reasons for 72-h
antibiotic prophylaxis administration included age more
than 65 years old, late tumor stage, prolonged operation
time, or suspicion of pneumonia after the operation.
The allocation was objectively dependent on patients’
conditions. Perioperative management protocols and
wound management were similar in both groups.
The primary endpoint was the incidence of SSI and
remote infection. Determination of the presence of SSI
was based on criteria developed by the CDC (10). Remote
infection complications, defined as a postoperative
infection at a site other than the surgical site, were defined
as recommended by the Clavien–Dindo classification (15),
such as pneumonia, enteritis, or urinary tract infection.
The chi-square test or Fisher’s exact test was used to
compare nominal variables. For comparison of continuous
variables, the Mann–Whitney U test was used. A binary

logistic regression model was used for multivariate
analysis. Univariate and multivariate logistic regression
analyses were applied to identify the factors independently
influencing the risk of development of infectious
complications. P < 0.05 was considered to denote statistical
significance. Statistical analyses were performed using
SPSS 13.0 (SPSS Inc., Chicago, IL, USA).
3. Results
Among the 1095 gastric cancer patients who underwent
elective surgery from July 2016 to January 2018, 105 cases
were excluded (combined resection n = 53, noncurative
resection n = 33, neoadjuvant chemotherapy n = 6, other
reasons n = 13; Figure). As summarized in Table 1, the
characteristics of these 990 included patients (708 in 24-h
group and 282 in 72-h group) were balanced except for
age. In the 72-h prophylaxis group the mean age was 64.2
± 11.2 years, which was significantly older than in the 24-h
prophylaxis group (61.6 ± 10.9 years).
The overall number of infections was 115 in the 24-h
prophylaxis group and 45 in the 72-h prophylaxis group
(P = 0.912). Regarding SSI, the overall incidence was
5.5% (54 of 990 patients). The incidence of SSI was 5.2%
in the 24-h prophylaxis and 6.0% in the 72-h prophylaxis
group, respectively. There were no significant differences
in superficial or deep incisional SSI or organ/space SSI
between the two groups (Table 2). On the basis of multiple
logistic regression analysis (Table 3), the odds ratios (ORs)
for surgical-site infections with 72 h of antimicrobial

Assessed for eligibility n=1095
Excluded:
Combined resection n=53
Non-curative resection n=33
neoadjuvant chemotherapy n=6
other reasons n=13
990 patients were enrolled according to the
including and excluding criteria

Allocated to 24h prophylaxis n=708

16Laparoscopic partial gastrectomy n=123

Laparoscopic total gastrectomy n=54

17open partial gastrectomy n=344

open total gastrectomy n=187

18

Figure. Flowchart of the presented study.
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Allocated to 72h prophylaxis n=282
Laparoscopic partial gastrectomy n=40
Laparoscopic total gastrectomy n=15
open partial gastrectomy n=142
open total gastrectomy n=85
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Table 1. Baseline and operative data.
24-h prophylaxis
n = 708
Age (years)*

61.6 (10.9)

72-h prophylaxis
P
n = 282
64.2 (11.2)

0.008

Sex ratio (M:F) 450:258

190:92

0.076

BMI (kg/m2)*

22.5 (3.4)

0.798

22.9 (9.6)

pT category

0.176

pT1

183 (25.8%)

75 (26.6%)

pT2

81 (11.4%)

21 (7.4%)

pT3–4

445 (62.8%)

186 (66.0%)

pN category
pN0

0.474
307 (43.4%)

122 (43.3%)

pN1

90 (12.7%)

44 (15.6%)

pN2

134 (18.9%)

56 (19.9%)

pN3

177 (25.0%)

60 (21.3%)

Pathological
stage

0.729

I

231 (32.6%)

86 (30.5%)

II

63 (8.9%)

21 (7.4%)

III

363 (51.3%)

152 (53.9%)

IV

51 (7.2%)

23 (8.2%)

During of
operation (h)

0.920

≥4

354 (50.0%)

142 (50.4%)

<4

354 (50.0%)

140 (49.6%)

Estimated
blood loss (mL)

0.330

≥150

96 (13.6%)

45 (16.0%)

<150

612 (86.4%)

237 (84.0%)

Intraoperative
blood
transfusion

0.535

Yes

45 (6.4%)

21 (7.4%)

No

663 (93.6%)

261 (92.6%)

Laparoscopy

0.065

Yes

177 (25.0%)

55 (19.5%)

No

531 (75.0%)

227 (80.5%)

Gastrectomy

0.671

prophylaxis were 1.03 (95% CI: 0.47–2.30) before and 1.15
(95% CI: 0.49–2.90) after adjusting for nine variables (age,
sex, BMI, duration of operation, estimated blood loss,
transfusions, postoperative cancer stage, laparoscopy, and
open and distal or total gastrectomy)
The incidence of remote infection was 11.0% in 24-h
prophylaxis and 9.9% in 72-h prophylaxis (Table 4). The
rate of pulmonary infection rate was lower in the 72-h
prophylaxis group but this was not significant (24-h
group 9.3% versus 72-h group 7.8%). In logistic regression
analysis (Table 5), the unadjusted OR for remote infection
after 72 h of prophylaxis was 0.89 (95% CI: 0.51–1.56).
The adjusted OR with 72 h of prophylaxis was 0.62 (95%
CI: 0.31–1.27) after accounting for nine variables (age,
sex, BMI, duration of operation, estimated blood loss,
transfusions, postoperative cancer stage, laparoscopy,
and open and distal or total gastrectomy). However, age
more than 60 years (OR: 2.08; 95% CI: 1.08–3.99) and
pathological stage ≥III (OR: 1.88; 95% CI: 1.02–3.48) were
independent risk factors for remote infection.
4. Discussion
This retrospective study was designed to compare the
incidence of SSI and remote infection in patients given
antibiotic prophylaxis for 24 h with that of patients
administered antibiotic prophylaxis for 72 h after elective
gastric cancer surgery. It was concluded that antibiotic
prophylaxis for 24 h does not increase the incidence of SSI
or remote infection in gastric cancer patients.
Antibiotic prophylaxis should be effectively given for
the shortest interval because extended use of antibiotics
is associated with great costs and might increase the risk
of adverse effects. However, controversies on the duration
of antibiotic prophylaxis still exist in clinical practice
(16,17). A survey in South Korea and Japan showed that
at 11 institutions antimicrobial prophylaxis was routinely
given for longer than 24 h after open gastrectomy (18).
However, national surgical infection prevention guidelines
in the United States recommend that antibiotics be
discontinued within 24 h of surgery. The reason behind
the longer use of antibiotics might be differences in the
extent of lymphadenectomy: differing from the extended
Table 2. Incidence of surgical-site infection.
24-h
prophylaxis
n = 708

72-h
prophylaxis
n = 282

P

37 (5.2%)

17 (6.0%)

0.616

Partial

467 (66.0%)

182 (64.5%)

Overall surgical-site
infections

Total

241 (34.0%)

100 (35.5%)

Superficial incisional 14 (2.0%)

6 (2.1%)

1.000

Deep incisional

6 (0.8%)

2 (0.7%)

1.000

Organ/space

18 (2.5%)

9 (3.2%)

0.571

*Values are mean (±SD); BMI = body mass index; pT = primary
tumor; pN = lymph node status.
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D2 lymphadenectomy in East Asia (4,19), D0 or D1
lymphadenectomy was generally accepted in the United
States and Europe (20,21). Most Japanese surgeons
believe that the surgical stress related to gastrectomy with

such lymph node dissection might deteriorate the host
immune system and increase the risk of postoperative
complications, including SSIs and remote infections,
which might be prevented by longer antibiotic use (9).

Table 3. Univariable and multivariable logistic regression analyses for the association between risk factors and surgicalsite infections.
Univariate analysis

72-h prophylaxis

Multivariate analysis

Odds ratio (95% CI)

P

Odds ratio (95% CI)

P

1.03 (0.47–2.30)

0.934

1.15 (0.49–2.90)

0.818

Age >60

1.27 (0.59–2.75)

0.538

1.39 (0.55–3.50)

0.492

Male sex

0.61 (0.30–1.27)

0.185

0.59 (0.25–1.37)

0.220

BMI ≥25 kg/m2

1.10 (0.40–3.03)

0.794

1.36 (0.48–3.82)

0.562

Duration of operation ≥4 h

0.84 (0.37–1.92)

0.683

0.71 (0.29–1.78)

0.470

Estimated blood loss ≥150 mL

0.91 (0.26–3.12)

1.000

0.70 (0.20–2.52)

0.586

Intraoperative blood transfusion

1.56 (0.46–5.36)

0.729

1.03 (0.47–2.30)

0.275

Pathological stage ≥III

1.97 (0.87–4.63)

0.100

1.78 (0.63–5.05)

0.276

Open

1.55 (0.58–4.10)

0.377

0.70 (0.20–2.49)

0.581

Total gastrectomy

2.17 (1.05–4.74)

0.032

2.32 (0.97–5.57)

0.058

Table 4. Incidence of remote infection.
24-h prophylaxis
n = 708

72-h prophylaxis
n = 282

P

Remote infections

78 (11.0%)

28 (9.9%)

0.617

Respiratory

66 (9.3%)

22 (7.8%)

0.448

Urinary tract

8 (1.1%)

5 (1.8%)

0.622

Enteritis

5 (0.7%)

2 (0.7%)

1.000

Table 5. Univariable and multivariable logistic regression analyses for the association between risk factors and remote infections.
Univariate analysis

Multivariate analysis

Odds ratio (95% CI)

P

Odds ratio (95% CI)

P

72-h prophylaxis

0.89 (0.51–1.56)

0.692

0.62 (0.31–1.27)

0.192

Age >60

2.41 (1.41–4.12)

0.001

2.08 (1.08–3.99)

0.029

Male sex

1.77 (1.06–2.99)

0.029

1.19 (0.64–2.22)

0.580

BMI ≥ 25 kg/m2

1.16 (0.62–2.17)

0.633

1.27 (0.63–2.54)

0.509

Duration of operation ≥4 h

1.31 (0.79–2.16)

0.297

1.19 (0.66–2.15)

0.566

Estimated blood loss ≥150 mL

1.39 (0.70–2.77)

0.342

0.77 (0.31–1.90)

0.564

Intraoperative blood transfusion

1.52 (0.68–3.32)

0.429

1.08 (0.51–2.81)

0.811

Pathological stage ≥III

1.36 (0.85–2.19)

0.198

1.88 (1.02–3.48)

0.043

Open

0.86 (0.51–1.45)

0.565

0.64 (0.33–1.24)

0.187

Total gastrectomy

1.20 (0.76–1.91)

0.43

0.66 (0.35–1.26)

0.209
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To date, four randomized controlled trials (RCTs)
(9,22–24) have examined the optimal duration of antibiotic
prophylaxis after gastric cancer surgery. Two studies
recruited patients receiving various types of surgery, such
as total gastrectomy, distal gastrectomy, and proximal
gastrectomy with D1 + D2 lymphadenectomy; the other two
studies focused on total gastrectomy and distal gastrectomy
respectively with D1–D3 lymphadenectomy. They all came
to the conclusion that 24 h of antimicrobial prophylaxis
did not increase the incidence of SSI after gastrectomy. In
this study, we focused on Chinese gastric cancer patients
undergoing gastrectomy with D2 lymphadenectomy.
Our findings about SSI were in agreement with those of
the above studies. Regarding remote infection, Takagane
et al. reported that shortened antimicrobial prophylaxis
might increase the incidence of remote infection in total
gastrectomy, especially pulmonary (22). In our study, 24
h of antimicrobial prophylaxis did not increase the risk
of remote infections including lung, urinary tract, and
enteritis infections. This result was similar to those of the
other two RCTs (9,23).
Several factors are reported to be associated with SSIs,
such as aging, obesity, malnutrition, prolonged operation,
and combined adjacent organ resection (9,25,26). In our
study, however, 24-h prophylaxis, age more than 60 years,
sex, BMI, operation time, estimated blood loss of more
than 150 mL, transfusion, pathological stage ≥III, open
surgery, and total gastrectomy were not significant risk
factors, which is in agreement with the findings of Takagane

et al. (22). For remote infection, the risk factors may be
different (27,28). In this study, age more than 60 years
and pathological stage ≥III were significantly associated
with remote infection, suggesting that advanced age
and pathological stage might increase the risk of remote
infection. Thus, for those patients, extended antimicrobial
prophylaxis, perioperative respiratory rehabilitation, and
early mobilization should be recommended to prevent
remote infection (22,29).
The present study has several limitations. This
retrospective research was performed at a single
institution. Thus, the retrospective nature of our database
may introduce inevitable bias compared to RCTs.
However, data originating from a single institution avoid
any interhospital variation and different perioperative
managements.
The results of the current study indicate that 24-h
antibiotic prophylaxis is adequate for preventing SSIs and
remote infections in patients undergoing gastrectomy with
D2 lymphadenectomy. However, for advanced age and
pathological stage III patients, treatments such as extended
antibiotics, rehabilitation, or early mobilization should be
given to take precautions against remote infection.
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